Critical roles of LGN/GPSM2 phosphorylation by PBK/TOPK in cell division of breast cancer cells

Genes Chromosomes and Cancer

Volumn 49, Issue 10, 2010, Pages 861-872

  Fukukawa, Chikako ^a   Ueda, Koji ^b   Nishidate, Toshihiko ^a   Katagiri, Toyomasa ^a,c   Nakamura, Yusuke ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b RIKEN   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; G PROTEIN SIGNALING MODULATOR 2; GUANINE NUCLEOTIDE BINDING PROTEIN; OLIGONUCLEOTIDE; PDZ BINDING KINSE LYMPHOKIN ACTIVATED KILLER T CELL ORIGINATED PORTEIN KINASE; PLASMID VECTOR; PROTEIN SERINE THREONINE KINASE; SMALL INTERFERING RNA; THREONINE; THREONINE 450; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DIVISION; CELL KINETICS; ENZYME INDUCTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; METAPHASE; MITOSIS; MITOSIS INHIBITION; NATURAL KILLER T CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA EXTRACTION; SITE DIRECTED MUTAGENESIS; SPINDLE CELL; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MITOSIS; MUTAGENESIS, SITE-DIRECTED; MUTATION; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 77957885917     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20795     Document Type: Article

References (30)

1. Ajiro M, Katagiri T, Ueda K, Nakagawa H, Fukukawa C, Lin ML, Park JH, Nishidate T, Daigo Y, Nakamura Y. 2009. Involvement of RQCD1 overexpression, a novel cancer-testis antigen, in the Akt pathway in breast cancer cells. Int J Oncol 35:673-681.
2. American Type Culture Collection (ATCC). 2009. Cell line verification test recommendations; ATCC recommends cell line verification tests and guidelines for publishing. ATCC Technical Bulletin: No. 8.
3. Bange J, Zwick E, Ullrich A. 2001. Molecular targets for breast cancer therapy and prevention. Nat Med 7:548-552.
4. Blumer JB, Chandler LJ, Lanier SM. 2002. Expression analysis and subcellular distribution of the two G-protein regulators AGS3 and LGN indicate distinct functionality. J Biol Chem 277:15897-15903.
5. Dobashi S, Katagiri T, Hirota E, Ashida S, Daigo Y, Shuin T, Fujioka T, Miki T, Nakamura Y. 2009. Involvement of TMEM22 overexpression in the growth of renal cell carcinoma cells. Oncol Rep 21:305-312.
6. Du Q, Macara IG. 2004. Mammalian Pins is a conformational switch that links NuMA to heterotimeric G proteins. Cell 119:503-516.
7. Du Q, Stukenberg PT, Macara IG. 2001. A mammalian partner of inscuteable binds NuMA and regulates mitotic spindle organization. Nat Cell Biol 3:1069-1075.
8. Du Q, Taylor L, Compton DA, Macara IG. 2002. LGN blocks the ability of NuMA to bind and stabilize microtubules: A mechanism for mitotic spindle assembly regulation. Curr Biol 12:1928-1933.
9. Hirota E, Yan L, Tsunoda T, Ashida S, Fujime M, Shuin T, Miki T, Nakamura Y, Katagiri T. 2006. Genome-wide gene expression profiles of clear cell renal cell carcinoma: Identification of molecular targets for treatment of renal cell carcinoma. Int J Oncol 29:799-827.
10. Kanehira M, Harada Y, Takata R, Shuin T, Miki T, Fujioka T, Nakamura Y, Katagiri T. 2007a. Involvement of upregulation of DEPDC1 (DEP domain containing 1) in bladder carcinogenesis. Oncogene 26:6448-6455.
11. Kanehira M, Katagiri T, Shimo A, Takata R, Shuin T, Miki T, Fujioka T, Nakamura Y. 2007b. Oncogenic role of MPHOSPHO1, a cancer-testis antigen specific to human bladder cancer. Cancer Res 67:3276-3285.
12. Kaushik R, Yu F, Chia W, Yang X, Bahri S. 2003. Subcellular localization of LGN during mitosis: Evidence for its cortical localization in mitotic cell culture systems and its requirement for normal cell cycle progression. Mol Biol Cell 14:3144-3155.
13. Lin ML, Park JH, Nishidate T, Nakamura Y, Katagiri T. 2007. Involvement of maternal embryonic leucine zipper kinase (MELK) in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of Bcl-2 family. Breast Cancer Res 9:R17.
14. Mochizuki N, Cho G, Wen B, Insel PA. 1996. Identification and cDNA cloning of a novel human mosaic protein, LGN, based on interaction with G alpha i2. Gene 181:39-43.
15. Nagayama S, Fukukawa C, Katagiri T, Okamoto T, Aoyama T, Oyaizu N, Imamura M, Toguchida J, Nakamura Y. 2005. Therapeutic potential of antibodies against FZD10, a cell-surface protein, for synovial sarcomas. Oncogene 24:6201-6212.
16. Nagayama S, Iiizumi M, Katagiri T, Toguchida J, Nakamura Y. 2004. Identification of PDZK4, a novel human gene with PDZ domains, that is upregulated in synovial sarcomas. Oncogene 23:5551-5557.
17. Navolanic PM, McCubrey JA. 2005. Pharmacological breast cancer therapy. Int J Oncol 27:1341-1344.
18. Nishidate T, Katagiri T, Lin ML, Mano Y, Miki Y, Kasumi F, Yoshimoto M, Tsunoda T, Hirata K, Nakamura Y. 2004. Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: Identification of genes associated with progression and metastasis. Int J Oncol 25:797-819.
19. Park JH, Lin ML, Nishidate T, Nakamura Y, Katagiri T. 2006. PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen having an oncogenic activity in breast cancer. Cancer Res 66:9186-9195.
20. Park JH, Nishidate T, Nakamura Y, Katagiri T. 2010. Critical roles of T-LAK cell-originated protein kinase in cytokinesis. Cancer Sci 101:403-411.
21. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J Clin 55:74-108.
22. Petricoin EF, III, Hackett JL, Lesko LJ, Puri RK, Gutman SI, Chumakov K, Woodcock J, Feigal DW, Jr., Zoon KC, Sistare FD. 2002. Medical applications of microarray technologies: A regulatory science perspective. Nat Genet 32(Suppl):474-479.
23. Petronczki M, Lénárt P, Peters JM. 2008. Polo on the rise-from mitotic entry to cytokinesis with Plk1. Dev Cell 14:646-659.
24. Saito-Hisaminato A, Katagiri T, Kakiuchi S, Nakamura T, Tsunoda T, Nakamura Y. 2002. Genome-wide profiling of gene expression in 29 normal human tissues with a cDNA microar-ray. DNA Res 9:35-45.
25. Shimo A, Nishidate T, Ohta T, Fukuda M, Nakamura Y, Katagiri T. 2007. Elevated expression of PRC1, protein regulator of cytokinesis 1, involved in the growth of breast cancer cells. Cancer Sci 98:174-181.
26. Shimokawa T, Furukawa Y, Sakai M, Li M, Miwa N, Lin YM, Nakamura Y. 2003. Involvement of the FGF18 gene in colorectal carcinogenesis, as a novel downstream target of the beta-catenin/T-cell factor complex. Cancer Res 63:6116-6120.
27. Togashi A, Katagiri T, Ashida S, Fujioka T, Maruyama O, Wakumoto Y, Sakamoto Y, Fujime M, Kawachi Y, Shuin T, Nakamura Y. 2005. Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy. Cancer Res 65:4817-4826.
28. Ueki T, Nishidate T, Park JH, Lin ML, Shimo A, Hirata K, Nakamura Y, Katagiri T. 2008. Involvement of elevated expression of multiple cell-cycle regulator, DTL/RAMP (denticleless/RA-regulated nuclear matrix associated protein), in the growth of breast cancer cells. Oncogene 27:5672-5683.
29. Vader G, Lens SMA. 2008. Aurora kinase family in cell division and cancer. Biochim Biophys Acta 1786:60-72.
30. Yasumi M, Sakisaka T, Hoshino T, Kimura T, Sakamoto Y, Yamanaka T, Ohno S, Takai Y. 2005. Direct binding of Lgl2 to LGN during mitosis and its requirement for normal cell division. J Biol Chem 280:6761-6765.